[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 342
Citations 0
Comment & Response
July 12, 2016

Vaccine Pricing and US Immunization Policies—Reply

Author Affiliations
  • 1Department of Pediatrics, Tufts University School of Medicine, Boston, Massachusetts
JAMA. 2016;316(2):226-227. doi:10.1001/jama.2016.6322

In Reply Dr Schwartz addresses cost in relation to meningococcal B vaccines and other health care expenditures. First, in terms of meningococcal B vaccines, the issues surrounding guidance for the use of these vaccines are quite complex apart from cost and are summarized in the Box. For example, both the efficacy and safety of the meningococcal B vaccines are incompletely understood.1 As noted, the risk of anaphylaxis following administration of this vaccine series may be equal to the likelihood of disease prevention.

First Page Preview View Large
First page PDF preview
First page PDF preview
×